🔎 Trials Near Me

Početna › Kronična bubrežna bolest › Illinois

Kliničke studije za Kronična bubrežna bolest u državi Illinois

17 studija za Kronična bubrežna bolest traži sudionike na lokacijama u državi Illinois.

Gradovi u državi Illinois

Službeni tekst studije (engleski)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Accellacare - DuPage, Lombard
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Champaign
  • Research Site, Maywood
  • Research Site, Rockford
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06742723

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

  • Comprehensive Transplant Center, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05106387

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Oak Brook
  • Research Site, Rockford
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT07624305

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07107945

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Research by Design, LLC - Internal Medicine, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07271186

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Champaign
  • Research Site, Chicago
  • Research Site, Chicago
  • i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07753993

Breakthrough - T1DM and Chronic Kidney Disease

  • The University of Chicago, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07592000

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaRana faza 1
Od 12 do 25 godina · Oba spola · Ažurirano 19. kol 2026. · NCT06430684

Study of BHV-1400 in IgA Nephropathy

  • Site-009, Hinsdale
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 23. lip 2026. · NCT07054684

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

  • Northwestern Memorial Hospital, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 22. svi 2026. · NCT01644903

Empagliflozin Treatment in Kidney Transplant Recipients

  • Edward Hines Jr. VA Hospital, Hines, IL, Hines
U tijeku regrutacijaFaza 4
Od 19 godina i više · Oba spola · Ažurirano 21. tra 2026. · NCT06013865

Kidney Precision Medicine Project

  • University of Illinois Chicago, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 14. tra 2026. · NCT04334707

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

  • Northwestern Memorial Hospital, Chicago
U tijeku regrutacijaFaza 1/2
Od 40 do 70 godina · Oba spola · Ažurirano 27. ožu 2026. · NCT06878560

Transformative Research in Diabetic Nephropathy

  • Northwestern University, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 do 100 godina · Oba spola · Ažurirano 27. velj 2026. · NCT02986984

Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

  • University of Chicago Medical Center, Chicago
U tijeku regrutacija
Od 18 do 70 godina · Oba spola · Ažurirano 14. stu 2025. · NCT06397456

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.